- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04686903
EuroPainClinicsStudy IX (EPCS IX)
Prospective Comparison Between Epiduroscopy Procedure, Racz Catheter Procedure and Caudal Epidural Block in Patients With FBSS
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
I. Epiduroscopy is an advanced proven diagnostic and therapeutic method for chronic radicular pain after spinal surgery. Moreover, this method is frequently used in patients with chronic low back pain conditions without previous spine surgery also known as "virgin back". Epiduroscopy allows by optical fiber technology and skiascopy imaging the exact examination of the epidural space and subsequently mechanical lysis (with advanced interventional options by laser, radiofrequency, balloon techniques etc.) and/or drug administration to the target point.
II. The Racz catheter procedure is based on epidural neurolysis. It is used to release some of the adhesions or scar tissue which surround entrapped nerves in the epidural space of the spine. This state could be caused by chronic inflammatory adhesions or by healing mechanisms after spine surgery - scars. Mechanical liberation of epidural space further allows better administration and targeting of drugs as corticoids or hyaluronidase. This technique is performed under fluoroscopy imaging. Suitable epidurogram and skiascopy confirm appropriate catheter position during procedure.
III. The caudal epidural block involves placing a needle through the sacral hiatus to deliver medications into the epidural space. This approach to the epidural space is popular in managing a wide variety of chronic pain conditions in adults, especially chronic low back pain syndromes. Fluoroscopy is considered as a gold standard of needle guidance during procedures in which caudal epidural injections are performed.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Bardejov, Slovakia, 085 01
- Europainclinics
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- patients aged between 20 and 80
- patients with FBSS (at least 1 - up to 2 lumbar laminectomies) who has radiating pain (VAS >=5) on lower extremities
- those who (only if a signature was obtainable), or whose legal guardian, fully understood the clinical trial details and signed the informed consent form
Exclusion Criteria:
- more than 2 lumbar laminectomies
- patients without previous spine surgery
- patients with a history of other spinal diseases (compression fracture, spondylitis, tumor)
- women with a positive pregnancy test before the trial or who planned to become pregnant within the following 3 years
- other patients viewed as inappropriate by the staff
- disagreement with participation in the study
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Epiduroscopy
Epiduroscopy in patients with FBSS
|
Device Epiduroscop, procedure mecahnical lysis, laser, radiofrequency + drug administration into the epidural space (corticosteroid methylprednisolone acetate 80mg and solution of hyaluronidase 150 I.U. in 10mL of saline) Follow-up: before procedure, 6 months and 12 months after procedure
|
Experimental: Racz catheter epidural procedure
Racz catheter epidural procedure in patients with FBSS
|
Device Racz catheter, two procedures during clinical trial observation
|
Experimental: Caudal epidural block
Caudal epidural block treatment of FBSS
|
Technique Caudal epidural block Three procedures during clinical trial observation :
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change from baseline EuroQoL-5 dimension (EQ-5D) value 6m
Time Frame: 6 months follow-up
|
EQ-5D-5L self-care, usual activities, pain/discomfort and anxiety/depression
|
6 months follow-up
|
Change from baseline EuroQoL-5 dimension (EQ-5D) value 12m
Time Frame: 12 months follow-up
|
EQ-5D-5L self-care, usual activities, pain/discomfort and anxiety/depression
|
12 months follow-up
|
Change from baseline Visual Analog Pain Scale (VAS) of back pain 6m
Time Frame: 6 months follow-up
|
VAS 10 point measurement
|
6 months follow-up
|
Change from baseline Visual Analog Pain Scale (VAS) of back pain 12 m
Time Frame: 12 months follow-up
|
VAS 10 point measurement
|
12 months follow-up
|
Oswestry disability index (ODI) 6m
Time Frame: 6 months follow-up
|
he ODI self-administered questionnaire measuring 0-100 scale function.''
The questionnaire comprises 10 items, each with 6 levels of response.
Each item is scored from 0 to 5, and the total summation is converted to a 0-100 scale.
The ODI scores range from 0 to 100, with higher scores indicating severe symptoms.
|
6 months follow-up
|
Oswestry disability index (ODI) 12m
Time Frame: 12 months follow-up
|
he ODI self-administered questionnaire measuring 0-100 scale function.''
The questionnaire comprises 10 items, each with 6 levels of response.
Each item is scored from 0 to 5, and the total summation is converted to a 0-100 scale.
The ODI scores range from 0 to 100, with higher scores indicating severe symptoms.
|
12 months follow-up
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Before procedure drug usage
Time Frame: before procedure
|
drug usage
|
before procedure
|
Postprocedural drug usage
Time Frame: before procedure
|
drug usage
|
before procedure
|
Radiation exposure
Time Frame: 12 months follow-up
|
Dose of radiation exposure
|
12 months follow-up
|
Collaborators and Investigators
Sponsor
Investigators
- Study Chair: Miroslav Burianek, MD MBA, Europainclinics z.ú.
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 03595/2020/OZ-30
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Failed Back Surgery Syndrome
-
Fundación Universidad Católica de Valencia San...Instituto de Investigación Biomédica de SalamancaNot yet recruitingFailed Back Surgery SyndromeSpain
-
Assiut UniversityNot yet recruitingFailed Back Surgery Syndrome
-
Poitiers University HospitalCompleted
-
Boston Scientific CorporationTerminatedPain | Back Pain | Failed Back Surgery SyndromeUnited States, United Kingdom, Canada, France
-
Moens MaartenCompleted
-
Jaseng Hospital of Korean MedicineCompletedFailed Back Surgery SyndromeKorea, Republic of
-
MedtronicNeuroTerminatedFailed Back Surgery SyndromeFrance, Germany, Belgium, Austria, Netherlands, Australia, Switzerland, United Kingdom, Spain, Israel
-
Poitiers University HospitalCompleted
-
University of Sao PauloCompletedLow Back Pain | Failed Back Surgery SyndromeBrazil
Clinical Trials on Epiduroscopy treatment
-
University of Sao PauloCompletedLow Back Pain | Failed Back Surgery SyndromeBrazil
-
Pavol Jozef Safarik UniversityEuropainclinics z.ú.Unknown
-
Instituto de Investigación Sanitaria de la Fundación...CompletedSpinal Stenosis, Lumbar Region, With Neurogenic ClaudicationSpain
-
PfizerCompleted
-
PfizerCompleted
-
Chiesi Farmaceutici S.p.A.Completed
-
Gilead SciencesCompletedChronic Lymphocytic LeukemiaUnited States
-
JW PharmaceuticalCompletedHealthyKorea, Republic of
-
PfizerCompleted
-
AstraZenecaParexelCompleted